Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110)

Heinrich, Kathrin ; Modest, Dominik P. ; Ricard, Ingrid ; Fischer von Weikersthal, Ludwig ; Decker, Thomas ; Kaiser, Florian ; Graeven, Ullrich ; Uhlig, Jens ; Schenk, Michael ; Freiberg-Richter, Jens ; Peuser, Bettina ; Denzlinger, Claudio ; Giessen-Jung, Clemens ; Stahler, Arndt ; Michl, Marlies ; Held, Swantje ; Jung, Andreas ; Kirchner, Thomas ; Stintzing, Sebastian ; Heinemann, Volker

European journal of cancer (1990), 2021-04, Vol.147, p.128-139 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available